Steris Analyst Ratings
Steris Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/26/2023 | 1.69% | Piper Sandler | $220 → $215 | Maintains | Neutral |
| 09/25/2023 | 18.25% | Stephens & Co. | → $250 | Reiterates | Overweight → Overweight |
| 09/01/2023 | 25.34% | JMP Securities | $240 → $265 | Maintains | Market Outperform |
| 08/03/2023 | 6.42% | Morgan Stanley | $206 → $225 | Maintains | Equal-Weight |
| 08/03/2023 | 22.03% | Keybanc | $254 → $258 | Maintains | Overweight |
| 08/02/2023 | 13.52% | JMP Securities | → $240 | Reiterates | Market Outperform → Market Outperform |
| 07/25/2023 | 20.14% | Keybanc | $235 → $254 | Maintains | Overweight |
| 07/17/2023 | 18.25% | Stephens & Co. | $240 → $250 | Maintains | Overweight |
| 05/30/2023 | -2.56% | Morgan Stanley | → $206 | Initiates Coverage On | → Equal-Weight |
| 05/12/2023 | -5.4% | Piper Sandler | $197 → $200 | Maintains | Neutral |
| 05/12/2023 | 11.15% | Keybanc | $210 → $235 | Maintains | Overweight |
| 05/11/2023 | 13.52% | JMP Securities | → $240 | Reiterates | Market Outperform → Market Outperform |
| 04/14/2023 | -6.82% | Piper Sandler | $215 → $197 | Downgrades | Overweight → Neutral |
| 02/15/2023 | 13.52% | JMP Securities | $250 → $240 | Maintains | Market Outperform |
| 02/10/2023 | 1.69% | Piper Sandler | $235 → $215 | Maintains | Overweight |
| 02/09/2023 | 4.06% | Stephens & Co. | → $220 | Maintains | Overweight |
| 11/11/2022 | -0.67% | Keybanc | $240 → $210 | Maintains | Overweight |
| 09/23/2022 | — | Needham | Downgrades | Buy → Hold | |
| 08/04/2022 | 12.1% | Needham | $248 → $237 | Maintains | Buy |
| 08/04/2022 | 13.52% | Keybanc | $256 → $240 | Maintains | Overweight |
| 07/14/2022 | 13.52% | Piper Sandler | → $240 | Initiates Coverage On | → Overweight |
| 05/13/2022 | 17.3% | Needham | $263 → $248 | Maintains | Buy |
| 02/14/2022 | 27.71% | JMP Securities | $250 → $270 | Maintains | Market Outperform |
| 02/10/2022 | 24.4% | Needham | $254 → $263 | Maintains | Buy |
| 11/04/2021 | 27.71% | Stephens & Co. | $255 → $270 | Maintains | Overweight |
| 11/04/2021 | 21.09% | Keybanc | $239 → $256 | Maintains | Overweight |
| 08/11/2021 | 18.25% | Baird | $230 → $250 | Maintains | Outperform |
| 08/11/2021 | 20.61% | Stephens & Co. | $217 → $255 | Maintains | Overweight |
| 08/11/2021 | 13.05% | Keybanc | $227 → $239 | Maintains | Overweight |
| 05/26/2021 | 10.21% | Needham | → $233 | Upgrades | Hold → Buy |
| 05/11/2021 | 11.15% | JMP Securities | $217 → $235 | Maintains | Market Outperform |
| 03/11/2021 | 7.37% | Keybanc | $224 → $227 | Maintains | Overweight |
| 02/04/2021 | 5.95% | Keybanc | → $224 | Upgrades | Sector Weight → Overweight |
| 09/02/2020 | -17.23% | Baird | → $175 | Initiates Coverage On | → Outperform |
| 06/09/2020 | — | Needham | Initiates Coverage On | → Hold | |
| 03/23/2020 | -31.42% | Stephens & Co. | $177 → $145 | Maintains | Overweight |
| 02/12/2020 | -16.28% | Stephens & Co. | $165 → $177 | Maintains | Overweight |
| 07/10/2019 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 05/22/2019 | -29.05% | JMP Securities | $135 → $150 | Maintains | Market Outperform |
| 05/15/2019 | -34.73% | Keybanc | $135 → $138 | Maintains | Overweight |
| 12/06/2018 | -25.74% | Sidoti & Co. | $155 → $157 | Maintains | Buy |
| 11/13/2018 | -37.57% | Keybanc | $120 → $132 | Maintains | Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年10月26日 | 1.69% | 派珀·桑德勒 | $220→$215 | 维护 | 中性 |
| 09/25/2023 | 18.25% | 斯蒂芬斯公司 | →$250 | 重申 | 超重→超重 |
| 09/01/2023 | 25.34% | JMP证券 | $240→$265 | 维护 | 市场表现强于大盘 |
| 08/03/2023 | 6.42% | 摩根士丹利 | $206→$225 | 维护 | 等重 |
| 08/03/2023 | 22.03% | KeyBanc | $254→$258 | 维护 | 超重 |
| 08/02/2023 | 13.52% | JMP证券 | →$240 | 重申 | 市场表现优于→市场表现 |
| 07/25/2023 | 20.14% | KeyBanc | $235→$254 | 维护 | 超重 |
| 07/17/2023 | 18.25% | 斯蒂芬斯公司 | $240→$250 | 维护 | 超重 |
| 2023年05月30日 | -2.56% | 摩根士丹利 | →$206 | 开始承保 | →等重 |
| 2023年05月12日 | -5.4% | 派珀·桑德勒 | $197→$200 | 维护 | 中性 |
| 2023年05月12日 | 11.15% | KeyBanc | $210→$235 | 维护 | 超重 |
| 2023年05月11日 | 13.52% | JMP证券 | →$240 | 重申 | 市场表现优于→市场表现 |
| 04/14/2023 | -6.82% | 派珀·桑德勒 | $215→$197 | 评级下调 | 超重→中性 |
| 02/15/2023 | 13.52% | JMP证券 | $250→$240 | 维护 | 市场表现强于大盘 |
| 02/10/2023 | 1.69% | 派珀·桑德勒 | $235→$215 | 维护 | 超重 |
| 02/09/2023 | 4.06% | 斯蒂芬斯公司 | →$220 | 维护 | 超重 |
| 2022年11月11日 | -0.67% | KeyBanc | $240→$210 | 维护 | 超重 |
| 09/23/2022 | - | 李约瑟 | 评级下调 | 购买→Hold | |
| 08/04/2022 | 12.1% | 李约瑟 | $248→$237 | 维护 | 买 |
| 08/04/2022 | 13.52% | KeyBanc | $256→$240 | 维护 | 超重 |
| 07/14/2022 | 13.52% | 派珀·桑德勒 | →$240 | 开始承保 | →超重 |
| 2022年05月13日 | 17.3% | 李约瑟 | $263→$248 | 维护 | 买 |
| 02/14/2022 | 27.71% | JMP证券 | $250→$270 | 维护 | 市场表现强于大盘 |
| 02/10/2022 | 24.4% | 李约瑟 | $254→$263 | 维护 | 买 |
| 11/04/2021 | 27.71% | 斯蒂芬斯公司 | $255→$270 | 维护 | 超重 |
| 11/04/2021 | 21.09% | KeyBanc | $239→$256 | 维护 | 超重 |
| 2021/08/11 | 18.25% | 贝尔德 | $230→$250 | 维护 | 跑赢大盘 |
| 2021/08/11 | 20.61% | 斯蒂芬斯公司 | $217→$255 | 维护 | 超重 |
| 2021/08/11 | 13.05% | KeyBanc | $227→$239 | 维护 | 超重 |
| 2021/05/26 | 10.21% | 李约瑟 | →$233 | 升级 | 持有→购买 |
| 2021/11/05 | 11.15% | JMP证券 | $217→$235 | 维护 | 市场表现强于大盘 |
| 03/11/2021 | 7.37% | KeyBanc | $224→$227 | 维护 | 超重 |
| 02/04/2021 | 5.95% | KeyBanc | →$224 | 升级 | 行业权重→超配 |
| 09/02/2020 | -17.23% | 贝尔德 | →$175 | 开始承保 | →跑赢大盘 |
| 06/09/2020 | - | 李约瑟 | 开始承保 | →保留 | |
| 03/23/2020 | -31.42% | 斯蒂芬斯公司 | $177→$145 | 维护 | 超重 |
| 02/12/2020 | -16.28% | 斯蒂芬斯公司 | $165→$177 | 维护 | 超重 |
| 2019年07月10日 | - | KeyBanc | 评级下调 | 增持→板块权重 | |
| 2019年05月22日 | -29.05% | JMP证券 | $135→$150 | 维护 | 市场表现强于大盘 |
| 2019年05月15日 | -34.73% | KeyBanc | $135→$138 | 维护 | 超重 |
| 2018年12月06日 | -25.74% | 西多蒂公司 | $155→$157 | 维护 | 买 |
| 2018年11月13日 | -37.57% | KeyBanc | $120→$132 | 维护 | 超重 |
What is the target price for Steris (STE)?
Steris(STE)的目标价是多少？
The latest price target for Steris (NYSE: STE) was reported by Piper Sandler on October 26, 2023. The analyst firm set a price target for $215.00 expecting STE to rise to within 12 months (a possible 1.69% upside). 17 analyst firms have reported ratings in the last year.
派珀·桑德勒于2023年10月26日报道了Steris(纽约证券交易所代码：STE)的最新目标价。这家分析公司将目标价定为215.00美元，预计STE将在12个月内升至(可能上涨1.69%)。过去一年，17家分析公司公布了评级。
What is the most recent analyst rating for Steris (STE)?
Steris(STE)的最新分析师评级是多少？
The latest analyst rating for Steris (NYSE: STE) was provided by Piper Sandler, and Steris maintained their neutral rating.
Piper Sandler提供了对Steris(纽约证券交易所代码：STE)的最新分析师评级，Steris维持其中性评级。
When is the next analyst rating going to be posted or updated for Steris (STE)?
Steris(STE)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Steris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Steris was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Steris的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Steris的上一次评级是在2023年10月26日提交的，所以你应该预计下一次评级将在2024年10月26日左右的某个时候提供。
Is the Analyst Rating Steris (STE) correct?
分析师评级Steris(STE)正确吗？
While ratings are subjective and will change, the latest Steris (STE) rating was a maintained with a price target of $220.00 to $215.00. The current price Steris (STE) is trading at is $211.42, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的斯特里斯(STE)评级维持不变，目标价在220.00美元至215.00美元之间。斯特里斯目前的交易价格为211.42美元，超出了分析师的预测区间。